Alkermes plc. (ALKS): Total Assets
$2.49B
As of 2025-12-31
$4.39B
As of 2026-06-30
+8.2%
3-year compound annual growth
+5.0%
5-year compound annual growth
+3.0%
10-year compound annual growth
| Period ended | Total Assets | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $2.49B | +21.0% | 2026-02-25, Balance as of period end |
| 2024-12-31 | $2.06B | -3.8% | 2026-02-25, Balance as of period end |
| 2023-12-31 | $2.14B | +8.8% | 2025-02-12, Balance as of period end |
| 2022-12-31 | $1.96B | -3.0% | 2024-02-21, Balance as of period end |
| 2021-12-31 | $2.02B | +3.8% | 2023-02-16, Balance as of period end |
| 2020-12-31 | $1.95B | +8.0% | 2022-02-16, Balance as of period end |
| 2019-12-31 | $1.81B | -1.1% | 2021-02-11, Balance as of period end |
| 2018-12-31 | $1.83B | +1.5% | 2020-02-13, Balance as of period end |
| 2017-12-31 | $1.80B | +4.1% | 2019-02-15, Balance as of period end |
| 2016-12-31 | $1.73B | -7.0% | 2018-02-16, Balance as of period end |
| 2015-12-31 | $1.86B | -3.3% | 2017-02-17, Balance as of period end |
| 2014-12-31 | $1.92B | +21.6% | 2016-02-25, Balance as of period end |
| 2013-12-31 | $1.58B | n/a | 2015-02-24, Balance as of period end |
| 2013-03-31 | $1.47B | +2.4% | 2013-05-23, Balance as of period end |
| 2012-03-31 | $1.44B | +217.2% | 2013-05-23, Balance as of period end |
| 2011-03-31 | $452.45M | n/a | 2012-05-18, Balance as of period end |
Total Assets at similar companies
| Company | Year ended | Total Assets | Change YoY |
|---|---|---|---|
| Alkermes plc. (ALKS) | 2025-12-31 | $2.49B | +21.0% |
| Phibro Animal Health Corp (PAHC) | 2026-06-30 | $1.50B | +10.3% |
| PTC Therapeutics, Inc. (PTCT) | 2025-12-31 | $2.90B | +70.0% |
| Indivior Pharmaceuticals, Inc. (INDV) | 2025-12-31 | $1.20B | -8.7% |
| Prestige Consumer Healthcare Inc. (PBH) | 2026-03-31 | $3.49B | +2.7% |
| Acadia Pharmaceuticals Inc (ACAD) | 2025-12-31 | $1.56B | +31.7% |
| Sarepta Therapeutics, Inc. (SRPT) | 2025-12-31 | $3.35B | -15.5% |
| Madrigal Pharmaceuticals, Inc. (MDGL) | 2025-12-31 | $1.26B | +20.9% |
| Ionis Pharmaceuticals Inc (IONS) | 2025-12-31 | $3.52B | +17.3% |
Compare ALKS, PAHC, PTCT, INDV side by side · Screen every company in Pharmaceutical Preparations ↗